JPRN-UMIN000015144
Completed
Phase 2
Phase II study of Carboplatin + nab-Paclitaxel followed by nab-Paclitaxel with chemotherapy naive advanced Non- Small Cell Lung Cancer - Phase II study of Carboplatin + nab-Paclitaxel followed by nab-Paclitaxel with chemotherapy naive advanced Non- Small Cell Lung Cancer
Fukuoka University School of Medicine0 sites40 target enrollmentSeptember 13, 2014
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Chemotherapy naive non-small cell lung cancer
- Sponsor
- Fukuoka University School of Medicine
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Active severe comorbidity disease. 2\) Interstitial pneumonia or pulmonary fibrosis on chest CT scans. 3\) Patients with symptomatic Brain metastases. 4\) Active concomitant malignancy. 5\) Active infectious disease. 6\) Pregnant or breast\-feeding females. 7\) Unstable psychic disorder. 8\) Accepted continuous use of steroid. 9\) Inappropriate patients for this study judged by the physicians.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase 2 study of Carboplatin plus nab-Paclitaxel for patients with PS 2 advanced NSCLC(TORG1426)on small cell lung cancerJPRN-UMIN000019458PO Thoracic Oncology Research Group42
Completed
Phase 2
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90
Recruiting
Phase 1
PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer.advanced non-squamous non-small cell lung cancerJPRN-UMIN000013333agoya City West Medical Center35
Completed
Phase 2
A Phase II Study of carboplatin plus paclitaxel for advanced thymic cancerThymic cancerJPRN-UMIN000001358West Japan Oncology Group40
Completed
Phase 2
Phase2 study of Carboplatin / Nab-paclitaxel + Bevacizumab to non-small-cell lung cancer (non-squamous cell carcinoma) with malignant pleural efussionon-small-cell lung cancer (non-squamous cell carcinoma) with malignant pleural efussion in stage4JPRN-UMIN000013329Osaka Prefectural Medical Center for Respiratory and Allergic diseases20